These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 974043

  • 1. Factor VIII and human platelet aggregation. III. Further studies on aggregation of humna platelets by neuraminidase-treated human factor VIII.
    Vermylen J, Bottecchia D, Szpilman H.
    Br J Haematol; 1976 Oct; 34(2):321-30. PubMed ID: 974043
    [Abstract] [Full Text] [Related]

  • 2. Factor VIII and human platelet aggregation. I. Evience that the platelet aggregating activity of bovine factor VIII is a property of its 'carrier protein' subunit.
    Bottecchia D, Vermylen J.
    Br J Haematol; 1976 Oct; 34(2):303-11. PubMed ID: 987796
    [Abstract] [Full Text] [Related]

  • 3. Factor VIII and human platelet aggregation. IV. Effect of proteolytic enzymes on platelet aggregation by factor VIII.
    Vermylen J, Bottecchia D.
    Br J Haematol; 1976 Oct; 34(2):331-40. PubMed ID: 135576
    [Abstract] [Full Text] [Related]

  • 4. Properties of human asialo-factor VIII. A ristocetin-independent platelet-aggregating agent.
    De Marco L, Shapiro SS.
    J Clin Invest; 1981 Aug; 68(2):321-8. PubMed ID: 6790574
    [Abstract] [Full Text] [Related]

  • 5. Studies on human antihemophilic factor. Evidence for a covalently linked subunit structure.
    Switzer ME, McKee PA.
    J Clin Invest; 1976 Apr; 57(4):925-37. PubMed ID: 1084890
    [Abstract] [Full Text] [Related]

  • 6. Molecular structural studies of human factor VIII.
    McKee PA, Andersen JC, Switzer ME.
    Ann N Y Acad Sci; 1975 Jan 20; 240():8-33. PubMed ID: 122889
    [Abstract] [Full Text] [Related]

  • 7. The effect of heparin on the interaction of factor VIII and human platelets in vitro.
    de Marco L, Fabris F, Molaro G, Girolami A.
    Haemostasis; 1977 Jan 20; 6(3):163-70. PubMed ID: 885379
    [Abstract] [Full Text] [Related]

  • 8. Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content.
    Weiss HJ, Hoyer LW, Rickles FR, Varma A, Rogers J.
    J Clin Invest; 1973 Nov 20; 52(11):2708-16. PubMed ID: 4542944
    [Abstract] [Full Text] [Related]

  • 9. The influence of thrombin on the platelet-aggregating activity of human factor VIII. A study with insolubilized thrombin.
    Vukovich T, Koller E, Doleschel W.
    Thromb Haemost; 1979 Oct 31; 42(3):832-7. PubMed ID: 505400
    [Abstract] [Full Text] [Related]

  • 10. Defective ristocetin-induced platelet aggregation in von Willebrand's disease and its correction by factor VIII.
    Weiss HJ, Rogers J, Brand H.
    J Clin Invest; 1973 Nov 31; 52(11):2697-707. PubMed ID: 4201262
    [Abstract] [Full Text] [Related]

  • 11. Interactions of purified rat factor VIII/von Willebrand factor with rat and human platelets--effect of albumin and ristocetin.
    Dejana E, Furlan M, Barbieri B, Donati MB, Beck EA.
    Thromb Haemost; 1984 Aug 31; 52(1):57-9. PubMed ID: 6437011
    [Abstract] [Full Text] [Related]

  • 12. The interaction of bovine factor VIII with human platelets.
    Kirby EP, Mills DC.
    J Clin Invest; 1975 Aug 31; 56(2):491-502. PubMed ID: 807600
    [Abstract] [Full Text] [Related]

  • 13. Effect of carbohydrate modifications of factor VIII/von Willebrand factor on binding to platelets.
    Goudemand J, Mazurier C, Samor B, Bouquelet S, Montreuil J, Goudemand M.
    Thromb Haemost; 1985 Jun 24; 53(3):390-5. PubMed ID: 2864750
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of human platelet aggregation by the proteolytic effect of streptokinase. Role of the human factor-VIII-related protein.
    Castillo R, Maragall S, Guisasola JA, Casals F, Profitós J, Ordinas A.
    Haemostasis; 1976 Jun 24; 5(5):306-17. PubMed ID: 1087912
    [Abstract] [Full Text] [Related]

  • 15. The agglutination of human platelets by botrocetin: evidence that botrocetin and ristocetin act at different sites on the factor VIII molecule and platelet membrane.
    Howard MA, Perkin J, Salem HH, Firkin BG.
    Br J Haematol; 1984 May 24; 57(1):25-35. PubMed ID: 6426499
    [Abstract] [Full Text] [Related]

  • 16. Effects on platelet function of removal of platelet sialic acid by neuraminidase.
    Greenberg J, Packham MA, Cazenave JP, Reimers HJ, Mustard JF.
    Lab Invest; 1975 Apr 24; 32(4):476-84. PubMed ID: 1127870
    [Abstract] [Full Text] [Related]

  • 17. The effects of neuraminidase treatment on the biological activities of factor VIII.
    Rosenfeld L, Kirby EP.
    Thromb Res; 1979 Apr 24; 15(1-2):255-61. PubMed ID: 113904
    [No Abstract] [Full Text] [Related]

  • 18. Characterization of a form of bovine factor VIII which does not aggregate human platelets.
    Kirby EP.
    Thromb Haemost; 1981 Aug 28; 46(2):479-84. PubMed ID: 6795738
    [Abstract] [Full Text] [Related]

  • 19. Studies on the mechanism of ristocetin-induced platelet aggregation: binding of factor VIII to platelets.
    Schneider-Trip MD, Jenkins CS, Kahlé LH, Sturk A, ten Cate JW.
    Br J Haematol; 1979 Sep 28; 43(1):99-112. PubMed ID: 508625
    [Abstract] [Full Text] [Related]

  • 20. An atypical von Willebrand's disease with hyperreactivity of platelet aggregation.
    Niiya K, Kubonishi I, Taguchi H, Miyoshi I.
    Acta Haematol; 1984 Sep 28; 71(3):158-64. PubMed ID: 6424380
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.